Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PsylliumWorks is a UK-based life sciences company specializing in the research and development of psyllium-based health solutions. The company leverages expertise in material science and rheology to transform psyllium husk into high-performance functional ingredients and therapeutic agents for gastrointestinal and metabolic health. Their work focuses on improving the texture, solubility, and physiological impact of psyllium to address conditions such as irritable bowel syndrome (IBS) and chronic constipation. PsylliumWorks operates as a spin-out or close collaborator with the University of Nottingham, bridging the gap between academic research and commercial health products. The company's proprietary processing technology aims to enhance the efficacy and patient experience of fiber-based treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PsylliumWorks.